Table 4.

Clinical data of patients who developed DVT after the first dose of BNT162b2 mRNA vaccine

Sex	Female
Age	35 years old
Immunodeficiency	No
Year of HIV diagnosis	2013
CDC '93 classification	A2
Allergy to drugs	No
Osteopenia	Yes
Total cholesterol	209 mg/dl
LDL	116 mg/dl
HDL	75 mg/dl
Triglyceride	92 mg/dl
ART	DTG/ABC/3TC
Other therapy	Drospirenone, ethinylestradiol, cholecalciferol
HIV‐RNA, cp/ml	Not detectable
Previous SARS‐CoV‐2 infection	No

Abbreviations: ABC, abacavir; ART, antiretroviral therapy; DTG, dolutegravir; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; 3TC, lamivudine.